As of 2025-09-18, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (34.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.20 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -200.2%.
The range of the Relative Valuation is (26.86) - (45.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.5x - 11.5x | 8.0x |
| Forward P/E multiples | 6.8x - 12.1x | 9.4x |
| Fair Price | (26.86) - (45.32) | (34.26) |
| Upside | -178.5% - -232.5% | -200.2% |
| Date | P/E |
| 2025-09-17 | -8.71 |
| 2025-09-16 | -8.68 |
| 2025-09-15 | -8.60 |
| 2025-09-12 | -8.66 |
| 2025-09-11 | -8.59 |
| 2025-09-10 | -8.91 |
| 2025-09-09 | -9.29 |
| 2025-09-08 | -8.95 |
| 2025-09-05 | -9.07 |
| 2025-09-04 | -8.72 |
| 2025-09-03 | -8.82 |
| 2025-09-02 | -8.48 |
| 2025-08-29 | -7.89 |
| 2025-08-28 | -7.81 |
| 2025-08-27 | -7.74 |
| 2025-08-26 | -7.88 |
| 2025-08-25 | -7.66 |
| 2025-08-22 | -7.87 |
| 2025-08-21 | -7.49 |
| 2025-08-20 | -7.41 |
| 2025-08-19 | -7.49 |
| 2025-08-18 | -7.57 |
| 2025-08-15 | -7.82 |
| 2025-08-14 | -7.56 |
| 2025-08-13 | -7.66 |
| 2025-08-12 | -7.25 |
| 2025-08-11 | -6.97 |
| 2025-08-08 | -6.84 |
| 2025-08-07 | -7.10 |
| 2025-08-06 | -7.27 |
| 2025-08-05 | -7.45 |
| 2025-08-04 | -7.19 |
| 2025-08-01 | -7.09 |
| 2025-07-31 | -7.28 |
| 2025-07-30 | -7.44 |
| 2025-07-29 | -7.45 |
| 2025-07-28 | -7.72 |
| 2025-07-25 | -7.89 |
| 2025-07-24 | -7.74 |
| 2025-07-23 | -7.89 |
| 2025-07-22 | -7.76 |
| 2025-07-21 | -7.88 |
| 2025-07-18 | -7.92 |
| 2025-07-17 | -8.41 |
| 2025-07-16 | -8.12 |
| 2025-07-15 | -8.11 |
| 2025-07-14 | -8.41 |
| 2025-07-11 | -8.13 |
| 2025-07-10 | -8.15 |
| 2025-07-09 | -8.23 |